PDC and anemia: Given the pleiotropic and complex nature of the hypoxic response and the large number of components involved in the HIF system, it is likely important that clinically used PHD inhibitors are as selective as is possible for the desired physiological outcome, especially with regard to the long-term treatment of chronic diseases such as anaemia.